Evidence map›Paper›PMID 30531793›Full record

ArticleScientific reports2018

Publisher Correction: Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.

María E Rodríguez-Ortiz, Claudia Pontillo, Mariano Rodríguez, Petra Zürbig, Harald Mischak, Alberto Ortiz

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

María E Rodríguez-OrtizInstituto de Investigación Sanitaria Fundación Jiménez Díaz, Fundación Renal Iñigo Álvarez de Toledo, Universidad Autónoma de Madrid. REDinREN, Avda. Reyes Católicos, 2, 28040, Madrid, Spain. marien_rguez@hotmail.com.
Claudia PontilloMosaiques Diagnostics GmbH, Rotenburger Str. 20, 30659, Hannover, Germany.
Mariano RodríguezNephrology Service, Reina Sofía University Hospital/University of Córdoba. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC). Avda. Menéndez Pidal, S/N. 14004, Córdoba(Spain). REDinREN, Madrid, Spain.
Petra ZürbigMosaiques Diagnostics GmbH, Rotenburger Str. 20, 30659, Hannover, Germany.
Harald MischakMosaiques Diagnostics GmbH, Rotenburger Str. 20, 30659, Hannover, Germany.
Alberto OrtizInstituto de Investigación Sanitaria Fundación Jiménez Díaz, Fundación Renal Iñigo Álvarez de Toledo, Universidad Autónoma de Madrid. REDinREN, Avda. Reyes Católicos, 2, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0002-9805-9523

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Identifiers

PMID30531793
PMCPMC6287123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.